PRKAA1 and kidney injury: The selective AMPK inhibitor, Compound C, suppressed CDDP-induced AMPK activation, p53 phosphorylation, Bax induction, and caspase 3 activation both in vitro and in a mouse model of CDDP-induced kidney injury.